Reviewing Dementia Care After Medication Changes: Governance, Risk and Day-to-Day Practice Alignment

Medication changes in dementia care can quickly alter alertness, behaviour, mobility and risk. Within strong dementia assessment and review processes and clearly defined dementia service models, any new prescription, dosage adjustment or discontinuation should trigger structured reassessment rather than informal observation. Commissioners and inspectors expect to see that care plans, risk controls and staff guidance are updated promptly and proportionately. When medication is changed without review of day-to-day delivery, services risk avoidable falls, increased distress, over-sedation or unrecognised deterioration.

Why medication changes require structured review

In dementia services, medication adjustments commonly relate to pain management, antidepressants, antipsychotics, sleep aids, antibiotics, or cardiovascular treatments. Even small dosage changes can impact balance, appetite, sleep pattern, continence or communication. If staff are not clear about what to monitor and how to respond, early warning signs may be missed.

A structured review should consider: what has changed, what effects are expected, what risks may increase, and how staff should adjust support. It should also clarify how long the monitoring phase will last and who is responsible for escalation.

Core components of a post-medication review

• Clear documentation of the medication change and rationale.
• Identification of potential side effects relevant to dementia (sedation, confusion, orthostatic hypotension, agitation).
• Updated risk assessment (falls, choking, behavioural risk, self-neglect).
• Staff briefing at handover with practical monitoring instructions.
• Time-bound evaluation checkpoint (for example, 72 hours, 7 days, 4 weeks).

Operational example 1: Sedation after antipsychotic adjustment

Context: A resident with moderate dementia experienced increased agitation and was prescribed a low-dose antipsychotic adjustment by the GP. Within days, staff observed increased drowsiness and slower mobility.

Support approach: The service initiated a structured medication review pathway, focusing on falls risk, hydration, and safe mobility rather than attributing changes solely to “progression of dementia.”

Day-to-day delivery detail: Staff implemented assisted mobilisation during peak sedation times, ensured drinks were offered regularly due to reduced self-initiation, and documented alertness levels each shift. The falls risk assessment was updated to reflect slower reaction times. Handover briefings included clear guidance on when to escalate concerns to the GP.

How effectiveness was evidenced: Care notes demonstrated proactive support rather than reactive incident management. No falls occurred during the monitoring period, and hydration records remained stable. Governance review recorded the reassessment and documented GP follow-up discussion.

Operational example 2: Antibiotics causing temporary delirium

Context: A domiciliary care client started antibiotics for a chest infection and became acutely more confused, wandering at night and refusing meals.

Support approach: Rather than escalating supervision indefinitely, the service identified potential medication-related delirium and implemented a short-term review plan.

Day-to-day delivery detail: Night-time welfare checks were increased temporarily, environmental cues were simplified, and staff used short reassurance phrases. The plan included monitoring appetite and fluid intake. A clear end date for enhanced checks was documented, subject to improvement.

How effectiveness was evidenced: Behaviour stabilised after the antibiotic course ended. The service could evidence that temporary risk controls were proportionate and reviewed, with documentation showing removal of additional checks once safe.

Operational example 3: Pain management reducing distress but increasing falls risk

Context: Introduction of stronger analgesia significantly reduced distress behaviours in a residential setting, but staff observed mild dizziness on standing.

Support approach: The service balanced improved comfort with new mobility risk by updating moving and handling guidance and monitoring standing tolerance.

Day-to-day delivery detail: Staff implemented “sit-pause-stand” routines, ensured mobility aids were consistently positioned, and recorded postural stability observations during the first week. The care plan clarified supervision requirements during peak medication effect times.

How effectiveness was evidenced: Distress incidents reduced measurably while falls did not increase. Documentation showed balanced risk management and explicit review dates. Governance meeting minutes captured discussion of proportionality and outcome monitoring.

Commissioner expectation

Commissioners expect: Clear evidence that medication changes lead to structured reassessment of care delivery, risk and staffing instructions. They look for measurable impact — such as reduced distress, stable falls data, or improved engagement — alongside documented rationale and review intervals.

Regulator / inspector expectation (CQC)

CQC expects: Safe medicines management and responsive care. Inspectors will test whether staff understand side effects, whether risk assessments were updated promptly, and whether temporary restrictions or enhanced supervision are reviewed and reduced when no longer required.

Governance oversight that prevents medication-related drift

Strong services embed medication-change tracking into governance dashboards. Practical mechanisms include: a medication change log reviewed weekly, spot audits of care plan updates following prescription changes, supervision prompts asking “what changed and what did we adjust?”, and audit sampling of falls and incident data during monitoring periods. Restrictive measures introduced due to sedation or confusion should always include a documented review date.

When medication adjustments are treated as clinical events requiring operational alignment, services demonstrate mature, evidence-based dementia care rather than reactive practice.